医学
骨科手术
过敏性接触性皮炎
接触性皮炎
外科
氰基丙烯酸酯
氰基丙烯酸酯
皮肤病科
过敏
胶粘剂
化学
有机化学
免疫学
图层(电子)
作者
Bernadette Ricciardo,Rosemary Nixon,Mei Tam,Ross Radic,Brendan J. Ricciardo
出处
期刊:Orthopedics
[Slack Incorporated (United States)]
日期:2020-09-03
卷期号:43 (6): e515-e522
被引量:27
标识
DOI:10.3928/01477447-20200827-01
摘要
The Dermabond Prineo skin closure system (Ethicon, Somerville, New Jersey) is a wound closure device that combines a 2-octyl cyanoacrylate liquid adhesive and a self-adhesive polyester mesh. Although cyanoacrylates traditionally have been associated with low rates of sensitization, allergic contact dermatitis (ACD) to Dermabond products is being increasingly reported after orthopedic surgery. The authors describe the first case series of ACD to Dermabond Prineo where patch testing confirmed the diagnosis in all patients. Six patients who had suspected Dermabond Prineo ACD after lower limb orthopedic surgery were assessed. Of these patients, 5 had itching within 4 days of surgery and rash within 5 days. All 5 of these patients reported previous exposure to Dermabond products. All patients had removal of the adhesive and mesh earlier than planned and were treated with corticosteroids. In addition, 4 patients received systemic antibiotics; however, only 1 had a microbiologically confirmed superficial skin infection. In all patients, the dermatitis resolved within 2 weeks of dressing removal, with no adverse effect on the orthopedic outcome. Patch testing showed positive reactions to Dermabond Prineo glue for all patients. Orthopedic surgeons should be aware of the potential for ACD to Dermabond Prineo, especially among patients with previous exposure to Dermabond products. The authors discuss the risk factors for ACD to Dermabond Prineo in the orthopedic cohort and provide recommendations for prevention and management. [ Orthopedics . 2020;43(6):e515–e522.]
科研通智能强力驱动
Strongly Powered by AbleSci AI